# Genome editing

Reagents & kits — Programmable genome editors — CRISPR-Cas9, base and prime editors — delivered ex vivo or in vivo in lipid nanoparticles to treat genetic disease: from the first approved CRISPR therapy Casgevy to redosable in-vivo CRISPR and single-dose base editing for cardiovascular…

Source: https://en.bioecon.ru/market/reagents-kits/genome-editing/